INTRODUCTION: Biofilm formation on medical devices such as intravenous catheters is a serious manifestation of Pseudomonas aeruginosa infections. Serum has bactericidal activity, a function of multiple serum components. In this study, we determined the effect of serum and serum components on the formation of P. aeruginosa biofilm. MATERIALS AND METHODS: We examined the effect of adult bovine serum (ABS) or bovine serum albumin (BSA) on biofilm development on plastic coverslips. This was done using both static and continuous flow-through culture systems and P. aeruginosa strain PAO1. Biofilms were quantified using crystal violet assays and visualized using confocal scanning laser microscopy and scanning electron microscopy. We examined the effect of ABS on PAO1 swimming and twitching motilities (both contribute to P. aeruginosa biofilm development). We also analyzed the inhibitory effect of adult human serum (AHS) and plasma (AHP) on PAO1 biofilm development on plastic coverslips and intravenous catheters. RESULTS: Compared with M9 minimal medium (M9), 10% ABS-supplemented medium (M9/ABS-10) caused a significant decrease in biofilm development. Coverslips precoated with M9/ABS-10 failed to develop biofilm when placed in M9. In addition to reduced biofilm formation, adding ABS to M9 reduced an already-developed PAO1 biofilm. Compared with M9, M9/ABS-10 enhanced PAO1 twitching motility considerably, but did not affect swimming motility. Similar to ABS, BSA blocked biofilm formation but did not affect PAO1 twitching motility. Both AHS and AHP blocked PAO1 biofilm formation on plastic coverslips and intravenous catheters. CONCLUSIONS: These results suggest that as part of the host innate resistance, serum inhibits P. aeruginosa biofilm formation on plastic surfaces, including intravenous catheters. Two possible scenarios for this inhibition include blocking the direct interaction between P. aeruginosa and the substrates, and the enhancing P. aeruginosa twitching motility.
INTRODUCTION: Biofilm formation on medical devices such as intravenous catheters is a serious manifestation of Pseudomonas aeruginosa infections. Serum has bactericidal activity, a function of multiple serum components. In this study, we determined the effect of serum and serum components on the formation of P. aeruginosa biofilm. MATERIALS AND METHODS: We examined the effect of adult bovine serum (ABS) or bovine serum albumin (BSA) on biofilm development on plastic coverslips. This was done using both static and continuous flow-through culture systems and P. aeruginosa strain PAO1. Biofilms were quantified using crystal violet assays and visualized using confocal scanning laser microscopy and scanning electron microscopy. We examined the effect of ABS on PAO1 swimming and twitching motilities (both contribute to P. aeruginosa biofilm development). We also analyzed the inhibitory effect of adult human serum (AHS) and plasma (AHP) on PAO1 biofilm development on plastic coverslips and intravenous catheters. RESULTS: Compared with M9 minimal medium (M9), 10% ABS-supplemented medium (M9/ABS-10) caused a significant decrease in biofilm development. Coverslips precoated with M9/ABS-10 failed to develop biofilm when placed in M9. In addition to reduced biofilm formation, adding ABS to M9 reduced an already-developed PAO1 biofilm. Compared with M9, M9/ABS-10 enhanced PAO1twitching motility considerably, but did not affect swimming motility. Similar to ABS, BSA blocked biofilm formation but did not affect PAO1twitching motility. Both AHS and AHP blocked PAO1 biofilm formation on plastic coverslips and intravenous catheters. CONCLUSIONS: These results suggest that as part of the host innate resistance, serum inhibits P. aeruginosa biofilm formation on plastic surfaces, including intravenous catheters. Two possible scenarios for this inhibition include blocking the direct interaction between P. aeruginosa and the substrates, and the enhancing P. aeruginosa twitching motility.
Authors: Cassandra Kruczek; Mitchell Wachtel; Magdy S Alabady; Paxton R Payton; Jane A Colmer-Hamood; Abdul N Hamood Journal: Microbiology Date: 2011-11-03 Impact factor: 2.777
Authors: Phat L Tran; Nathan Lowry; Thomas Campbell; Ted W Reid; Daniel R Webster; Eric Tobin; Arash Aslani; Thomas Mosley; Janet Dertien; Jane A Colmer-Hamood; Abdul N Hamood Journal: Antimicrob Agents Chemother Date: 2011-11-28 Impact factor: 5.191
Authors: Adrienne A Hammond; Kyle G Miller; Cassandra J Kruczek; Janet Dertien; Jane A Colmer-Hamood; John A Griswold; Alexander R Horswill; Abdul N Hamood Journal: Burns Date: 2010-12-03 Impact factor: 2.744
Authors: Cecily L Haley; Cassandra Kruczek; Uzma Qaisar; Jane A Colmer-Hamood; Abdul N Hamood Journal: Can J Microbiol Date: 2014-01-24 Impact factor: 2.419
Authors: Chase Watters; Katrina DeLeon; Urvish Trivedi; John A Griswold; Mark Lyte; Ken J Hampel; Matthew J Wargo; Kendra P Rumbaugh Journal: Med Microbiol Immunol Date: 2012-09-25 Impact factor: 3.402